AJ, Y., & NS, R. (2012). Denosumab, a RANK ligand inhibitor, for the management of bone loss in cancer patients. Dove Medical Press.
Style de citation Chicago (17e éd.)AJ, Yee, et Raje NS. Denosumab, a RANK Ligand Inhibitor, for the Management of Bone Loss in Cancer Patients. Dove Medical Press, 2012.
Style de citation MLA (8e éd.)AJ, Yee, et Raje NS. Denosumab, a RANK Ligand Inhibitor, for the Management of Bone Loss in Cancer Patients. Dove Medical Press, 2012.
Attention : ces citations peuvent ne pas être correctes à 100%.